Literature DB >> 27781392

Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMP® ).

Michelle L Schoettler1, Dionne Graham2, Wen Tao3, Margaret Stack3, Elaine Shu3, Lauren Kerr2, Ellis J Neufeld1, Rachael F Grace1.   

Abstract

An observational approach is recommended in newly diagnosed children with immune thrombocytopenia (ITP) at low risk of bleeding; however, there is no standard definition of risk. A standardized clinical assessment and management plan (SCAMP® ), a modifiable practice guideline, was implemented and revised (SCAMP-1 and SCAMP-2) and applied to 71 newly diagnosed patients with ITP. The Buchanan and Adix bleeding score guided treatment and was modified by stratifying by low- and high-risk grade 3 bleeding in SCAMP-2. Observation rates increased from 40% to 74% from SCAMP-1 to SCAMP-2 (P < 0.05) with no bleeding complications. We propose a modified bleeding score that increased observation rates in low-risk patients with ITP.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  bleeding; guideline; immune thrombocytopenia; pediatrics; treatment

Mesh:

Year:  2016        PMID: 27781392      PMCID: PMC5366076          DOI: 10.1002/pbc.26303

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

1.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

Review 2.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

3.  Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study.

Authors:  T Kühne; P Imbach; P H Bolton-Maggs; W Berchtold; V Blanchette; G R Buchanan
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

4.  Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines.

Authors:  P H Bolton-Maggs; I Moon
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

5.  Decision modeling of disagreements: pediatric hematologists' management of idiopathic thrombocytopenic purpura.

Authors:  Harold P Lehmann; Nkossi Dambita; George R Buchanan; James F Casella
Journal:  Med Decis Making       Date:  2011-03-14       Impact factor: 2.583

6.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

7.  Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.

Authors:  Bethan Psaila; Aleksandra Petrovic; Lemke K Page; Jill Menell; Matthew Schonholz; James B Bussel
Journal:  Blood       Date:  2009-09-18       Impact factor: 22.113

Review 8.  Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology.

Authors:  J S Lilleyman
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

9.  Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopenia.

Authors:  Rachael F Grace
Journal:  Semin Hematol       Date:  2013-01       Impact factor: 3.851

10.  The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.

Authors:  Lemke K Page; Bethan Psaila; Drew Provan; J Michael Hamilton; Julian M Jenkins; Andrew S Elish; Martin L Lesser; James B Bussel
Journal:  Br J Haematol       Date:  2007-06-03       Impact factor: 6.998

View more
  2 in total

Review 1.  The Use of Clinical Scores in the Management of Immune Thrombocytopenic Purpura in Children.

Authors:  Vasile Eduard Roşu; Elena-Lia Spoială; Tamara Solange Roşu; Anca-Viorica Ivanov; Adriana Mocanu; Alecsandra Munteanu; Vasile Valeriu Lupu; Ingrith Miron; Cristina Gavrilovici
Journal:  Front Pediatr       Date:  2022-05-09       Impact factor: 3.569

2.  Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient.

Authors:  Adelina Raluca Marinescu; Voichita Elena Lazureanu; Virgil Filaret Musta; Narcisa Daniela Nicolescu; Alexandra Mocanu; Talida Georgiana Cut; Camelia Oana Muresan; Cristina Tudoran; Monica Licker; Ruxandra Laza
Journal:  Infect Drug Resist       Date:  2022-06-30       Impact factor: 4.177

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.